This review provides a detailed overview of recent investigations into the roles of IL-1 family cytokines in RA pathogenesis and critically examines the current status of drugs targeting these cytokines in clinical trials, thereby offering novel perspectives on the treatment of rheumatoid diseases. The gene discussed is IL1A; the disease is rheumatoid arthritis.